AG Barr is switching its attention to GlaxoSmithKline’s Lucozade and Ribena brands, following the collapse of its proposed merger with Britvic, according to UK reports.
UK: AG Barr switches attention from Britvic to Lucozade, Ribena – report
AG Barr is switching its attention to GlaxoSmithKline's Lucozade and Ribena brands, following the collapse of its proposed merger with Britvic, according to UK reports.